RIPRETINIB
UNII 9XW757O13D

Substance Identification & Data

This profile provides standardized clinical and technical data for Ripretinib, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 9XW757O13D.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1442472-39-0 and the RxNorm Concept ID (RxCUI) 2369389. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

9XW757O13D

CAS Registry Number

1442472-39-0

RxNorm Concept ID

2369389

Detailed Substance Profile

Preferred Name

RIPRETINIB

Official standardized name for this substance within the FDA UNII nomenclature system.

Molecular Formula

9XW757O13D

The specific atomic composition represented as a molecular structure string.

InChIKey

C24H21BrFN5O2

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

CEFJVGZHQAGLHS-UHFFFAOYSA-N

Line notation for describing the chemical structure and connectivity of atoms.

NCI Thesaurus

C124067

National Cancer Institute reference terminology for clinical and research data.

PubChem CID

71584930

Unique identification number in the NCBI database of chemical substances.

INN ID

10808

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

EF-104

Identifier assigned by the United States Adopted Names Council.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

c1(cc2c(n(c1=O)CC)cc(nc2)NC)-c3cc(c(cc3Br)F)NC(Nc4ccccc4)=O

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Ripretinib. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.